These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2446008)

  • 21. Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes.
    Zhang W; Auyong DB; Oaks JL; McGuire TC
    Virology; 1999 Sep; 261(2):242-52. PubMed ID: 10497109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus.
    Clabough DL; Gebhard D; Flaherty MT; Whetter LE; Perry ST; Coggins L; Fuller FJ
    J Virol; 1991 Nov; 65(11):6242-51. PubMed ID: 1717720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological comparison among various strains of equine infectious anemia virus.
    Kono Y; Kobayashi K; Fukunaga Y
    Arch Gesamte Virusforsch; 1971; 34(3):202-8. PubMed ID: 4330134
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunopathogenesis of equine infectious anemia lentivirus disease.
    McGuire TC; O'Rourke KI; Perryman LE
    Dev Biol Stand; 1990; 72():31-7. PubMed ID: 2178127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equine infectious anemia: detection of infections virus-antibody complexes in the serum.
    McGuire TC; Crawford TB; Henson JB
    Immunol Commun; 1972; 1(6):545-51. PubMed ID: 4141690
    [No Abstract]   [Full Text] [Related]  

  • 26. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
    Howe L; Leroux C; Issel CJ; Montelaro RC
    J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of viral persistence in equine infectious anemia.
    Coggins L
    Cornell Vet; 1975 Apr; 65(2):143-51. PubMed ID: 165036
    [No Abstract]   [Full Text] [Related]  

  • 28. Lentivirus cross-reactive determinants present in the capsid protein of equine infectious anaemia virus.
    Grund CH; Lechman ER; Issel CJ; Montelaro RC; Rushlow KE
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():657-62. PubMed ID: 7510329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.
    Cook RF; Berger SL; Rushlow KE; McManus JM; Cook SJ; Harrold S; Raabe ML; Montelaro RC; Issel CJ
    J Virol; 1995 Mar; 69(3):1493-9. PubMed ID: 7853482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease.
    Sponseller BA; Sparks WO; Wannemuehler Y; Li Y; Antons AK; Oaks JL; Carpenter S
    Virology; 2007 Jun; 363(1):156-65. PubMed ID: 17328936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.
    Mealey RH; Leib SR; Pownder SL; McGuire TC
    J Virol; 2004 Sep; 78(17):9295-305. PubMed ID: 15308724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural proteins of equine infectious anemia virus and their antigenic activity.
    Nishimura M; Nakajima H
    Am J Vet Res; 1984 Jan; 45(1):5-10. PubMed ID: 6322625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equine infectious anemia.
    Henson JB; McGuire TC
    Prog Med Virol; 1974; 18(0):143-59. PubMed ID: 4371283
    [No Abstract]   [Full Text] [Related]  

  • 34. Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain.
    Howe L; Craigo JK; Issel CJ; Montelaro RC
    J Gen Virol; 2005 Jan; 86(Pt 1):139-149. PubMed ID: 15604441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.
    Mealey RH; Sharif A; Ellis SA; Littke MH; Leib SR; McGuire TC
    Virology; 2005 Aug; 339(1):110-26. PubMed ID: 15979679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of a cell membrane antigen by equine infectious anemia virus.
    McGuire TC; Crawford TB
    Am J Vet Res; 1978 Mar; 39(3):385-6. PubMed ID: 205145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunology of a persistent retrovirus infection--equine infectious anemia.
    McGuire TC; Crawford TB
    Adv Vet Sci Comp Med; 1979; 23():137-59. PubMed ID: 95154
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs.
    Kono Y; Hirasawa K; Fukunaga Y; Taniguchi T
    Natl Inst Anim Health Q (Tokyo); 1976; 16(1):8-15. PubMed ID: 177894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
    Hammond SA; Li F; McKeon BM; Cook SJ; Issel CJ; Montelaro RC
    J Virol; 2000 Jul; 74(13):5968-81. PubMed ID: 10846078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.